Thermo Fisher Scientific (TMO) Total Debt (2009 - 2026)

Thermo Fisher Scientific has disclosed Total Debt across 18 years of filings, most recently posting $43.2 billion for Q1 2026.

• Quarterly Total Debt rose 26.24% year-over-year to $43.2 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $43.2 billion (up 26.24% YoY) and the FY2025 annual result came in at $39.4 billion, up 25.93% from the prior year.
• Total Debt advanced to $43.2 billion in Q1 2026, from $39.4 billion in the prior quarter.
• Over five years, Total Debt peaked at $43.2 billion in Q1 2026 and troughed at $29.2 billion in Q4 2022.
• A 5-year average of $34.8 billion and a median of $35.2 billion in 2025 frame the typical range for Total Debt.
• Annual changes were most pronounced in 2022 — Total Debt soared 78.36% — and 2024, when it fell 10.43%.
• Tracing TMO's Total Debt over 5 years: stood at $34.5 billion in 2022, then climbed by 1.24% to $34.9 billion in 2023, then declined by 10.43% to $31.3 billion in 2024, then advanced by 25.93% to $39.4 billion in 2025, then rose by 9.59% to $43.2 billion in 2026.
• Business Quant data shows TMO's Total Debt at $43.2 billion in Q1 2026, $39.4 billion in Q4 2025, and $35.7 billion in Q3 2025.